logo

Progenics Pharmaceuticals Inc (PGNX)



Trade PGNX now with
  Date
  Headline
5/9/2018 7:55:03 AM Progenics Pharma Q1 Net Loss $13.4 Mln Or $0.19/Shr Vs Loss Of $16.4 Mln Or $0.23/Shr Last Year
3/19/2018 8:33:52 AM Progenics Pharma Announces Presentation Of AZEDRA Biochemical Tumor Marker Data
3/8/2018 7:50:03 AM Progenics Pharmaceuticals Q4 Revenue $3.9 Mln, Net Loss Attributable $2.7 Mln Or $0.04 Per Share
6/30/2012 10:30:40 AM Salix Pharma: What's The Buzz?
2/21/2012 6:52:21 AM Take Two : Progenics Pharma
7/2/2008 8:47:23 AM Friedman Billings Ramsey Downgrades Progenics Pharmaceuticals Inc (PGNX) To Underperform From Market Perform With $12 Up From $9 Price Target
4/24/2008 9:39:52 PM Progenics Pharmaceuticals (PGNX) Announces $15Mln. Stock Repurchase Plan
3/12/2008 2:58:40 PM Friedman Billings Ramsey Cuts Progenics Pharmaceuticals (PGNX) To Market Perform From Outperform With $8 Down From $35 Price Target